Healthcare provider profile · identity verified

Robert Southerland, MD

Family Practice · SALEM, NY · NPI 1730613514

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	157
Omeprazole	Omeprazole	298	92
Lisinopril	Lisinopril	292	97
Amlodipine Besylate	Amlodipine Besylate	274	89
Gabapentin	Gabapentin	248	53
Levothyroxine Sodium	Levothyroxine Sodium	226	64
Metoprolol Succinate	Metoprolol Succinate	199	67
Rosuvastatin Calcium	Rosuvastatin Calcium	199	60
Losartan Potassium	Losartan Potassium	162	57
Sertraline Hcl	Sertraline Hcl	143	34
Simvastatin	Simvastatin	134	44
Albuterol Sulfate Hfa	Albuterol Sulfate	131	45
Metformin Hcl	Metformin Hcl	130	37
Furosemide	Furosemide	103	36
Trazodone Hcl	Trazodone Hcl	99	31
Hydrochlorothiazide	Hydrochlorothiazide	91	33
Tamsulosin Hcl	Tamsulosin Hcl	90	32
Pantoprazole Sodium	Pantoprazole Sodium	87	27
Eliquis	Apixaban	86	18
Metoprolol Tartrate	Metoprolol Tartrate	80	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	25
Duloxetine Hcl	Duloxetine Hcl	77	17
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	74	suppressed
Tramadol Hcl	Tramadol Hcl	74	20
Pregabalin	Pregabalin	73	12
Ozempic	Semaglutide	72	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	72	18
Prednisone	Prednisone	71	50
Fluoxetine Hcl	Fluoxetine Hcl	68	11
Jardiance	Empagliflozin	67	17
Fluticasone Propionate	Fluticasone Propionate	66	24
Ondansetron Odt	Ondansetron	66	19
Hydroxyzine Hcl	Hydroxyzine Hcl	65	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	25
Clopidogrel	Clopidogrel Bisulfate	61	24
Metformin Hcl Er	Metformin Hcl	60	20
Potassium Chloride	Potassium Chloride	58	17
Doxycycline Hyclate	Doxycycline Hyclate	54	49
Lorazepam	Lorazepam	53	11
Celecoxib	Celecoxib	52	13
Famotidine	Famotidine	51	13
Alendronate Sodium	Alendronate Sodium	45	14
Escitalopram Oxalate	Escitalopram Oxalate	45	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	18
Allopurinol	Allopurinol	44	12
Clonazepam	Clonazepam	44	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	15
Cephalexin	Cephalexin	41	32
Montelukast Sodium	Montelukast Sodium	40	13
Trulicity	Dulaglutide	39	12
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	34
Clonidine Hcl	Clonidine Hcl	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	13
Lovastatin	Lovastatin	37	12
Alprazolam	Alprazolam	36	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Entresto	Sacubitril/Valsartan	35	suppressed
Irbesartan	Irbesartan	35	suppressed
Finasteride	Finasteride	34	suppressed
Spironolactone	Spironolactone	33	13
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Azithromycin	Azithromycin	31	30
Rybelsus	Semaglutide	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	12
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Diazepam	Diazepam	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Baclofen	Baclofen	23	suppressed
Glipizide	Glipizide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Atenolol	Atenolol	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	11
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	20	suppressed
Carisoprodol	Carisoprodol	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Methylprednisolone	Methylprednisolone	19	17
Mirtazapine	Mirtazapine	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Fluconazole	Fluconazole	15	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Naproxen	Naproxen	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Topiramate	Topiramate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error